Cite
HARVARD Citation
Bhattacharya, I. et al. (2015). Eligibility for Entry into First Line Metastatic Trials in Patients with Disease Recurrence within 12 Months of Adjuvant Chemotherapy for Early Stage Breast Cancer. Clinical oncology. 27 (6), pp. e10-. [Online].